Antifungal Meds Cut Risk for Death After Lung Transplant
MONDAY, Oct. 26, 2020 -- Preventive antifungal medications cut the risk for death following a lung transplant by more than half, according to a study published online Sept. 23 in the Annals of the American Thoracic Society.
Kelly M. Pennington, M.D., from the Mayo Clinic in Rochester, Minnesota, and colleagues evaluated the effect of antifungal prophylaxis on all-cause mortality and invasive fungal infections (IFI) in lung transplant patients. The analysis included 667 lung transplant recipients (385 received prophylaxis and 282 did not) who were identified through administrative claims data (2005 through 2018).
The researchers found that all-cause mortality was significantly lower in those receiving antifungal prophylaxis versus those not (event rate per 100 person-years: 8.77 versus 18.50; hazard ratio, 0.48; 95 percent confidence interval, 0.26 to 0.71; P = 0.003). There were also lower rates of IFI seen among patients receiving antifungal prophylaxis versus those not receiving prophylaxis (event rate per 100 person-years: 15.09 versus 22.48; hazard ratio, 0.68; 95 percent confidence interval, 0.45 to 1.05; P = 0.08).
"This is the first study to demonstrate a mortality benefit associated with the use of antifungal prophylaxis in lung transplant patients," Pennington said in a statement. "We still do not know which lung transplant patients receive the most benefit from these medications, and there are other unanswered questions that will require more research."
© 2021 HealthDay. All rights reserved.
Posted: October 2020
Read this next
FRIDAY, Jan. 8, 2021 -- Adoption of a virtual platform has allowed continued maintenance of a large kidney transplant program despite the inability to have in-person visits during...
WEDNESDAY, Dec. 30, 2020 -- Use of kidney biopsy results from deceased donor kidneys does not improve prediction of allograft survival, according to a study published online Dec....
FRIDAY, Dec. 18, 2020 -- Recipients of kidneys from donors infected with hepatitis C virus (HCV) have similar kidney allograft function and probability of rejection in the first...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.